BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15168054)

  • 1. Pediatric embryonal tumor with epithelial immunophenotype showing absence of hSNF5/INI1 expression.
    Sakai K; Shigeta H; Ogiso Y; Hongo K; Kobayashi S; Hirose T
    Childs Nerv Syst; 2005 Feb; 21(2):150-5. PubMed ID: 15168054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric embryonal tumor of the cerebellum with rhabdoid cells and novel intracytoplasmic inclusions: distinction from atypical teratoid/rhabdoid tumor.
    Sasaki A; Kurihara H; Ishiuchi S; Hirato J; Saito N; Nakazato Y
    Acta Neuropathol; 2005 Jul; 110(1):69-76. PubMed ID: 15965700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
    Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
    J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
    Fujisawa H; Takabatake Y; Fukusato T; Tachibana O; Tsuchiya Y; Yamashita J
    J Neurooncol; 2003 Jul; 63(3):257-62. PubMed ID: 12892231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical teratoid/rhabdoid tumor of the pineal region in an adult.
    Takei H; Adesina AM; Mehta V; Powell SZ; Langford LA
    J Neurosurg; 2010 Aug; 113(2):374-9. PubMed ID: 19911885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
    Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
    BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
    Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
    J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma.
    Judkins AR; Burger PC; Hamilton RL; Kleinschmidt-DeMasters B; Perry A; Pomeroy SL; Rosenblum MK; Yachnis AT; Zhou H; Rorke LB; Biegel JA
    J Neuropathol Exp Neurol; 2005 May; 64(5):391-7. PubMed ID: 15892296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Intracranial Atypical Teratoid/Rhabdoid Tumors: A Clinicopathologic and Neuroradiologic Study.
    Zhao RJ; Wu KY; Zhang JG; Ma YH; Kong LF
    J Child Neurol; 2015 Jul; 30(8):1017-23. PubMed ID: 25323739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumors.
    Miller S; Ward JH; Rogers HA; Lowe J; Grundy RG
    Brain Pathol; 2013 Jan; 23(1):19-27. PubMed ID: 22672440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].
    Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.
    Caramel J; Quignon F; Delattre O
    Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ
    Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity.
    Tsai CY; Wong TT; Lee YH; Chao ME; Lin SC; Liu DJ; Liang ML; Wang HW; Ho DM
    Am J Surg Pathol; 2012 Jan; 36(1):128-33. PubMed ID: 22020042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
    Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
    Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cribriform neuroepithelial tumor (CRINET): a nonrhabdoid ventricular tumor with INI1 loss and relatively favorable prognosis.
    Hasselblatt M; Oyen F; Gesk S; Kordes U; Wrede B; Bergmann M; Schmid H; Frühwald MC; Schneppenheim R; Siebert R; Paulus W
    J Neuropathol Exp Neurol; 2009 Dec; 68(12):1249-55. PubMed ID: 19915490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
    Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
    Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.